|
Volumn 51, Issue 5, 2001, Pages 316-320
|
Complementary & alternative methods update
a,c b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROGEN;
ANESTHETIC AGENT;
ASCORBIC ACID;
BIOLOGICAL MARKER;
CHOLESTEROL;
CIMICIFUGA RACEMOSA EXTRACT;
DNA;
ECHINACEA EXTRACT;
EPHEDRA EXTRACT;
FREE RADICAL;
GARLIC EXTRACT;
GINKGO BILOBA EXTRACT;
GINSENG EXTRACT;
HERBACEOUS AGENT;
HYPERICUM PERFORATUM EXTRACT;
KAVA EXTRACT;
LIGNAN;
LIPID;
LIPID HYDROPEROXIDE;
OMEGA 3 FATTY ACID;
PLACEBO;
SCAVENGER;
TAMOXIFEN;
TESTOSTERONE;
VALERIAN;
BLEEDING;
BREAST CANCER;
CANCER RISK;
CANCER SURVIVAL;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIET SUPPLEMENTATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG METABOLISM;
DRUG POTENTIATION;
FEMALE;
GENE MUTATION;
GENOTOXICITY;
HOT FLUSH;
HUMAN;
HYPOGLYCEMIA;
IN VITRO STUDY;
IN VIVO STUDY;
LINSEED;
LOW FAT DIET;
MALE;
MENOPAUSAL SYNDROME;
METABOLITE;
NOTE;
PERIOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL;
SWEATING;
TABLET FORMULATION;
VITAMIN SUPPLEMENTATION;
|
EID: 0035570703
PISSN: 00079235
EISSN: None
Source Type: Journal
DOI: 10.3322/canjclin.51.5.316 Document Type: Note |
Times cited : (4)
|
References (4)
|